Compound ID | 508
WQ-2765
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Upon infection of quinolone resistant- S. aureus into mice the effective dose was 2.5mg/kg in comparison to tosufloxacin with >100mg/ml |
| Description: | Hayashi N, Amano H, Ohshita Y, et al. In vitro and in vivo acctivities, pharmacokinetics and toxicity of WQ-2756 and WQ-2765. |
| Institute where first reported: | Wakunaga Pharmaceuticals, Japan |
| Year first mentioned: | 1996 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.